Cell Biology

RSS

Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has completed a financing round, extending its total Series A funding to $19 million.

17 Sep 2025

AI breakthrough offers a new way to predict and visualize disease processes

To solve a problem, we have to see it clearly. Whether it's an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer's patients, visualizing disease processes in the body is the first step toward alleviating human suffering. It's also often the most difficult and costly.

16 Sep 2025

New imaging technique enhances live-cell visualization in standard lab setups

Optical diffraction tomography (ODT) has long been recognized for its potential in non-invasive, label-free imaging of live biological cells. However, a major challenge arises when ODT is applied to standard multi-well cell culture plates, a common tool use under realistic laboratory conditions for biological studies.

16 Sep 2025

FUJIFILM Biosciences introduces BalanCD HEK293 perfusion a medium to enable gene therapy production

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

15 Sep 2025

Normal cells working together can sense far beyond their environment

The story of the princess and the pea evokes an image of a highly sensitive royal young woman so refined, she can sense a pea under a stack of mattresses.

13 Sep 2025

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors.

From Sino Biological Inc. 13 Sep 2025

Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics

Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation, AI, and real-time process control.

From Labman 13 Sep 2025

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

From BioDlink 12 Sep 2025

Nanobody-based strategy targets survivin to weaken cancer cells

Cancer cells have many strategies for resisting therapy. One such strategy is survivin, a protein that drives the division of diseased cells and prevents them from dying.

10 Sep 2025

Brain lateralization shapes the mental number line in newborn chicks

Lateralization of the brain – the tendency for the left and right hemispheres to specialize in different functions – underlies the development of a left-to-right mental number line, according to a study in newborn chicks.

10 Sep 2025

Microbial piracy offers clues to fighting antimicrobial resistance

Researchers have discovered how 'pirate phages' hijack other viruses to break into bacteria, sharing new genetic material for dangerous traits.

10 Sep 2025

Detecting causality in neural spike trains using a new technique

Understanding the brain's functional architecture is a fundamental challenge in neuroscience. The connections between neurons ultimately dictate how information is processed, transmitted, stored, and retrieved, thus forming the basis of our cognitive functions.

10 Sep 2025

Cancer cells found to use ketones as alternate fuel for growth

When it comes to their survival, cancer cells have a host of backup plans.

8 Sep 2025

BioDlink fast-tracks global growth with bevacizumab launch in Colombia and Pakistan

BioDlink announced that its self-developed bevacizumab injection biosimilar has received marketing approval from Colombia’s National Institute for Surveillance of Medicines and Foods (INVIMA) and Pakistan’s Drug Regulatory Authority of Pakistan (DRAP).

From BioDlink 8 Sep 2025

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

Axxam S.p.A., a premier provider of integrated early drug discovery services, and B'SYS GmbH, a specialist in ion channel biology, are pleased to announce a strategic collaboration focused on enabling access to validated ion channel cell lines for hit and lead identification through high-throughput electrophysiological screening.

From Axxam S.p.A 8 Sep 2025

Cell Biology

Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline

AI breakthrough offers a new way to predict and visualize disease processes

New imaging technique enhances live-cell visualization in standard lab setups

FUJIFILM Biosciences introduces BalanCD HEK293 perfusion a medium to enable gene therapy production

Normal cells working together can sense far beyond their environment

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

Nanobody-based strategy targets survivin to weaken cancer cells

Brain lateralization shapes the mental number line in newborn chicks

Microbial piracy offers clues to fighting antimicrobial resistance

Detecting causality in neural spike trains using a new technique

Cancer cells found to use ketones as alternate fuel for growth

BioDlink fast-tracks global growth with bevacizumab launch in Colombia and Pakistan

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

New method advances RNA velocity analysis with spatial and multi batch integration

Targeting ADAR1 offers new hope against glioblastoma

Research reveals how neutrophils orchestrate the mobilization of zinc to fight microbes

BioDlink expands ecosystem alliance to empower biotech innovators worldwide

Fluidic Sciences acquires business and assets of Sphere Bio to accelerate single-cell and protein interaction discovery

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest Life Science News